Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Researcher in mathematics ranks among world’s top peer reviewers
2016-10-07

Description: Abdon Peer Review Tags: Abdon Peer Review

Prof Abdon Atangana, from the UFS Institute
for Groundwater Studies.
Photo: Johan Roux

Thirty-year-old Prof Abdon Atangana has received the prestigious Sentinels of Science Award 2016. This award honours the highest achievers in peer review across the world’s journals. The elite contributors to scholarly peer review and editorial pursuits internationally are also honoured with this award. Recipients have demonstrated an outstanding, expert commitment to protecting the integrity and accuracy of published research in their field.

Prof Atangana, who ranks number one in the mathematics discipline with a merit of 324, is a professor at the Institute for Groundwater Studies at the University of the Free State (UFS).

He is editor of 17 international journals, editor-in-chief of two international journals and also reviewer of more than 200 international accredited journals. He has been lead and guest editor of some special issues. He is also editor of 19 journals of applied mathematics and mathematics and has presented and participated in more than 20 international conferences.

Prof Atangana’s research interests are methods and applications of partial and ordinary differential equations, fractional differential equations, perturbations methods, asymptotic methods, iterative methods, and groundwater modelling.

“Editors in more than 100 journals
trust my opinion to assess
whether a submitted paper
can be published or not.”

Peer review requires a respected expert in a given field

According to the professor, reviewers play a central role in scholarly publishing. “In the academic field, peer review is the process of subjecting an author’s scholarly work, research, or ideas to the scrutiny of others who are experts in the same field, before a paper describing this work is published in a journal or as a book. The peer review process helps the publisher to decide whether the work should be accepted, considered acceptable with revisions, or rejected.

“Peer review requires a respected expert in a given field, who is qualified and able to perform the review in a given timeframe. Due to the impact of my research papers in the field of mathematics and applied mathematics, and also my international recognition in the field of applied mathematics, many editors in more than 100 journals of applied mathematics trust my opinion to assess whether a submitted paper in a given journal of mathematics and applied mathematics can be published or not. Only this year I was able to review more than 100 papers from different journals of applied mathematics, applied physics, mathematics, engineering and hydrology,” he said.

A successful peer reviewer displays passion for the development of science

Key to his success as peer reviewer is his passion for the development of science, his ability to write fair reports about a given manuscript, as well as his knowledge on what has been done and what are the challenges in a given field to be able to give a report that will help the advancement of science.

Currently he is developing new mathematics tools that will be used to accurately model statistical problems as well as physical problems with many layers.

“To be the number one peer reviewer in the world in mathematics is a product of love, patience and determination to enhance science,” Prof Atangana said.

His advice to young researchers is to put their trust in God and to work hard. “Not necessarily for money but for love because the future of Africa is in the hands of young Africans,” he said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept